[EN] TRITERPENOID COMPOUNDS AND METHODS OF USE THEREOF<br/>[FR] COMPOSÉS TRITERPÉNOÏDES ET PROCÉDÉS POUR LES UTILISER
申请人:BIOTECHNOLOGY RES CORP LTD
公开号:WO2010032123A1
公开(公告)日:2010-03-25
The present invention provides therapeutically active compounds and compositions as receptor antagonists and methods of use thereof. In one aspect, the compounds are useful in modulating pain, inflammation and acute phase reactions by inhibiting the PGE2 receptors including PGE2 EP1, EP2 and EP4 receptors.
A series of 23-hydroxybetulinic acidderivatives were prepared and tested in vitro as a new class of inhibitors of glycogenphosphorylase (GP). Within this series of compounds, 12b (IC50 = 3.5 μM) is the most potent GPa inhibitor. The preliminary SAR results of the 23-hydroxybetulinic acidderivatives are discussed.